If you feel less energetic or your interest in sex has changed, it is reasonable to bring those concerns to a clinician. It is less useful to assume testosterone explains them before an assessment. Many symptoms overlap with sleep problems, medication effects, illness, and other changes that deserve their own attention.
This guide, checked September 22, 2026, follows Endocrine Society guidance and FDA information. It is meant to help you understand the conversation around testing, not diagnose you from a result. Turning 50 does not create an automatic need for TRT, and a low number without context is not the whole diagnosis.
KEEP IN MIND
The useful bits.
- Symptoms and consistently low testosterone belong together in the diagnostic assessment.
- Guidance recommends repeat morning fasting confirmation.
- A birthday, a subscription, or one result does not automatically justify TRT.
Begin with the changes that brought you to the appointment
Tell the clinician what changed, when it started, and how it affects your daily activities. Discuss sexual symptoms, sleep, relevant illnesses, medicines and supplements, and any previous testosterone use. A specific history is more useful than saying you want a higher number or a return to how you felt at a particular age.
The assessment should connect symptoms or signs with biochemical evidence and look for the cause. The provider reviews describe published enrollment pathways, but those commercial processes do not replace an individualized medical evaluation. A worthwhile appointment may end with another investigation instead of a testosterone prescription.
Sources: Endocrine Society: testosterone therapy clinical guidance
Repeat morning testing helps confirm the finding
The Endocrine Society recommends diagnosing male hypogonadism only with compatible symptoms or signs and consistently low testosterone. It recommends repeat morning fasting measurement to confirm an initial low result. Ask the clinician for preparation instructions and make sure collection times and laboratory reference ranges are available for interpretation.
Do not use this guide to select your own diagnostic cutoff. Measurement methods, clinical circumstances, and sometimes additional tests matter. If two results differ, ask what could explain the difference and what should happen next. A convenient at-home test or a broad panel does not answer that interpretive question on its own.
Sources: Endocrine Society: testosterone therapy clinical guidance
Sometimes the clinician needs more than total testosterone
Guidance recommends considering free testosterone when indicated, including situations where total testosterone is near a lower limit or conditions may alter sex hormone-binding globulin. The appropriate method and interpretation belong with the clinician. A second measurement is not simply a way to choose whichever number best fits an expectation.
Additional evaluation can help distinguish problems involving the testes from problems in the signaling pathway that controls testosterone production. Ask what each further test is intended to clarify. Understanding the purpose can make a staged evaluation feel less confusing without encouraging self-diagnosis from a collection of flagged laboratory values.
Sources: Endocrine Society: testosterone therapy clinical guidance
Age does not settle the benefit-risk decision
The guideline advises against routinely prescribing testosterone to all men aged 65 or older solely because of low concentrations. Selected men may be considered individually after discussion of potential benefits and risks. FDA labeling retains limitations around age-related hypogonadism. Neither statement supports treating aging itself as a universal indication.
For someone between 50 and 65, the same need for a sound diagnosis remains. Provider age windows, such as those discussed in our Henry review, are enrollment criteria rather than universal medical rules. Ask the clinician to explain the reason for treatment in your circumstances.
Sources: Endocrine Society: testosterone therapy clinical guidance · FDA: 2025 testosterone labeling and blood pressure changes
Raise fertility and relevant health history before a prescription
Testosterone can suppress sperm production, so mention any current or future fertility goals. The assessment also needs relevant prostate, blood-count, cardiovascular, and sleep history. Some findings may make treatment unsuitable or require further evaluation; a remote service still needs those conversations.
Ask how blood pressure and blood counts would be monitored if treatment proceeds. The FDA’s 2025 label changes included blood-pressure warnings and did not remove all testosterone risks. Our cost and monitoring checklist helps you ask who reviews results and who responds if concerns arise.
Sources: Endocrine Society: testosterone therapy clinical guidance · FDA: 2025 testosterone labeling and blood pressure changes
Leave with an understandable next step
Request the result with its units, reference range, and the clinician’s explanation. Clarify whether the next step is repeat testing, investigation of another cause, discussion of a medicine, or observation over time. Ask when you should hear back and how to follow up if the promised explanation does not arrive.
If treatment is proposed, identify the exact product before comparing routes or prices. Read injections versus gel and approved versus compounded testosterone as preparation. The goal is a decision you understand, supported by the medical evidence relevant to you.
Sources: Endocrine Society: testosterone therapy clinical guidance
Sources you can check
Provider pages describe commercial offers. Medical references provide context. Checked September 22, 2026; prices and availability can change.
Educational information for adults, not a diagnosis or treatment plan. Discuss symptoms and treatment decisions with a licensed clinician. Do not change a prescription based on this article.